Wisconsin 2025-2026 Regular Session

Wisconsin Assembly Bill AB273

Introduced
5/19/25  
Refer
5/19/25  
Report Pass
6/20/25  
Refer
6/20/25  
Engrossed
6/24/25  
Refer
6/27/25  
Enrolled
10/15/25  
Chaptered
12/10/25  

Caption

An Act to amend 15.405 (5g) of the statutes; Relating to: the membership of the Controlled Substances Board.

Summary

AB273 amends Wisconsin Statutes section 15.405 (5g) to revise the membership of the Controlled Substances Board. The board remains housed in the Department of Safety and Professional Services and continues to include the attorney general, the secretary of health services, the secretary of agriculture, trade and consumer protection, or their designees; the chairs of the pharmacy examining board, medical examining board, physician assistant affiliated credentialing board, dentistry examining board, and board of nursing, or a designee; plus one psychiatrist and one pharmacologist appointed to three-year terms. The bill is a narrow administrative change focused on board composition rather than on controlled-substance policy, enforcement, or scheduling rules. By updating the statute governing who sits on the board, it affects how the state’s controlled-substances oversight body is structured and who participates in advising or administering related regulatory functions.

Impact

The bill amends the statute establishing the Controlled Substances Board, changing state law only as to board membership and not altering the board’s core duties. It affects the Department of Safety and Professional Services and the professional licensing and public health officials who serve on or are represented on the board, as well as the appointed psychiatrist and pharmacologist positions.

Sentiment

Based on the available record, there is no evidence of controversy, recorded opposition, or substantive debate. The bill appears to have been treated as a routine statutory update, and the absence of committee transcripts or vote details suggests limited public contention or discussion.

Contention

No specific points of contention are documented in the available materials. Because there are no committee transcripts or recorded votes provided, it is not possible to identify any opposing arguments or named stakeholders who objected to the membership changes. The bill’s narrow scope likely reduced the chance of disagreement.

Companion Bills

WI SB274

Crossfiled An Act to amend 15.405 (5g) of the statutes; Relating to: the membership of the Controlled Substances Board.

Previously Filed As

WI SB274

The membership of the Controlled Substances Board.

WI SB0405

Controlled substances: other; definition of governmental agency under the administration of opioid antagonist act; modify. Amends sec. 101 of 2019 PA 39 (MCL 15.671). TIE BAR WITH: SB 404'25

WI SB2250

Relating To The Promotion Of Controlled Substances.

WI HB680

AN ACT relating to controlled substances.

WI HB1549

Relating To Controlled Substances.

WI HB2083

Relating To The Promotion Of Controlled Substances.

WI SB262

An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act.

WI SB0399

Controlled substances: drug paraphernalia; definition of drug paraphernalia; modify. Amends sec. 7451 of 1978 PA 368 (MCL 333.7451).

WI SB2418

Relating To Controlled Substances.

WI SB0404

Controlled substances: other; opioid antagonist policy; require schools to implement in certain circumstances. Amends sec. 1178 of 1976 PA 451 (MCL 380.1178) & adds sec. 1179c. TIE BAR WITH: SB 405'25

Similar Bills

No similar bills found.